SVE NEWS & France 24 Sharing Series – EU could approve two Covid-19 vaccines this year, Von der Leyen says

EU-could-approve-two-Covid-19-vaccines-this-year-Von-der-Leyen-says.png

The European Union could approve two coronavirus vaccines being tested by Pfizer-BioNTech and by Moderna before the end of next month, EU Commission president Ursula von der Leyen said Thursday. 

Speaking after a video summit of EU leaders, von der Leyen said the European Medicines Agency could give “conditional marketing authorisation… as early as the second half of December if all proceeds now without any problem”.

Working together, US giant Pfizer and Germany’s BioNTech have developed a vaccine the firms say has had successful clinical trials and have sent data to the EMA.

US biotech company Moderna has said its experimental vaccine is 95 percent effective.

The Amsterdam-based EMA will have to study test results before recommending that Brussels gives its approval, but — speaking after talks with EU leaders — von der Leyen was cautiously optimistic.

The European Union has contracts to reserve hundreds of millions of doses of future vaccines with BioNTech, Purevac, AstraZeneca and Sanofi if they can be brought to market.

“And we continue negotiations with Moderna, and we are in talks with Novavax,” von der Leyen said, adding that all 27 EU leaders had voiced support for the EU buying program.

She stressed that in the case of US firms, the EMA was in daily contact with its American equivalent the FDA.

“And if all proceeds with no problems. EMA tells us that the conditional marketing authorisation for BioNTech and Moderna could happen as early as the second half of December 2020.”

Earlier in the day, BioNTech co-founder Ugur Sahin told AFP that the firm was hoping for quick approval.

Shipments delayed?

“We are working at full speed,” he said, confirming the companies plan to apply for emergency use authorisation of their jab in the US on Friday, while European regulators will receive another batch of data “next week”.

“There is a chance that we can receive approval from the US or Europe or both regions this year still,” said Sahin, who is also BioNTech’s chief executive.

“We may even start delivering the vaccine in December,” he added, “if everyone works together very closely.”

But, earlier this week, Moderna CEO Stephane Bancel warned that protracted negotiations with Brussels over a contract to reserve his vaccine could delay shipments.

“It is clear that with a delay this is not going to limit the total amount but it is going to slow down delivery,” he told AFP, in an interview.

Pfizer/BioNTech and Moderna have taken the lead in the global chase for a vaccine, after large-scale trial data this month showed their jabs were around 95 percent effective against Covid-19.

The twin breakthroughs have lifted hopes for an end to a pandemic that has infected more than 56 million people and caused more than 1.3 million deaths worldwide since the virus first emerged in China late last year.

(AFP)

 

 

Sources from: France 24

SVE NEWS is the leader in world news liberal sharing.

(Comments on this news are welcome)
2020 CWMALLS: Standard, Sharing,Ecology, Value;
2020 CWMALLS COMMODITY: Patent, Technology, Art, Intelligence;
2020 CWMALLS NEW SPECIES: Keen, Aggressive, Personality, Value;
2020 MWE FUND: Charity, Public Welfare, Responsibility;

Tips: Due to the influence of Coronavirus, the 2020 Northern Hemisphere will be very cold, so please pay attention to the CWMALLS patented products series in order to prepare for prevention; consumers, distributors, live broadcasters, opinion leaders and other partners in Europe region, North America region, Asia Pacific region, please pay attention to CWMALLS NEWS! According to the prediction of CWMALLS Weather, 2020 winter of Northern Hemisphere (especially in North American region and European region) will be much colder than previous years, the situation in the movie The Day After Tomorrow might happen, hope everyone (especially the middle-aged and elderly people with diseases like cardiovascular disease, arthritis, scapulohumeral periarthritis, etc., and friends who live in cold areas, high altitude areas and extremely cold areas) to prepare for keeping out the cold! Scientific and reasonable prevention makes life become easier and more wonderful! Meanwhile, CWMALLS® Patented Product Series is also provided with Custom Made, Personal Tailor services, and appreciated and interacted synchronously via Google, Bing, Facebook, Twitter,YouTube, Pinterest , LinkedIn, VK and other sharing platforms; welcome worldwide web celebrities, fashion icons, opinion leaders, columnists and other friends, partners to comprehend and cooperate actively! Thank you! In 2020 CWMALLS people, CWMALLS team, CWMALLS complex will bring you more surprises and values!

    Top